 |
 FUNDACIÓN LILLY AWARD FOR PRECLINICAL BIOMEDICAL RESEARCH
As part of its vocation to contribute to the development of health in Spain at the service of its citizens and encouraged by the great welcome it received from the Scientific Community for the first Fundación Lilly Awards for Biomedical Research, whose presentation ceremony was honoured by the President of Spain who chaired the event, the Fundación Lilly has announced the second year of its awards.
Spain is a European Union member State which is currently at a crucial stage in its consolidation as an economic and industrial power. In order to achieve this status in both areas, we have to make a clear commitment to appropriate scientific development.
Support for research, scientific development and technological innovation offers a response to arguments to increase our contribution to the development of knowledge and its applications, and to break free from our excessive technological dependence.
|
 |
Javier Ellena. Chairman of the Fundación Lilly
José A Gutierrez. Director of the Fundación Lilly
Mariano Barbacid. Chairman of the Fundación Lilly Scientific Advisory Board |
|
In order to achieve these goals, the Public Administrations are working to increase the available resources, but we shall only be capable of achieving these objectives as set out in the National R&D and I Plan for 2000-2003 if a decisive contribution is made by the private sector, which in the pharmaceutical sector could amount to a significant sum.
The primary task of the pharmaceutical industry is to produce drugs which contribute to maintaining or improving the health of our citizens, in accordance with the current level of knowledge. This implies the sector's participation in and support for research, promoting innovation and the improvement of the therapeutic potential to combat illnesses.
|
|
2002 Fundación Lilly Biomedical Reseasch Award Ceremony |
| 2003 Announcement |
Fundación Lilly award for
PRECLINICAL BIOMEDICAL RESEARCH |
Fundación Lilly award for
CLINICAL BIOMEDICAL RESEARCH |
 The Award consists of a total sum of 195,000 €, of which the Award winner will receive the sum of 50,000 € as a research prize.
The remaining 145,000 € will be used to support the Award winner's research activity.
The amounts intended for supporting the Award winner's research activity will be paid in three annual instalments, starting in the year when the award was presented, of 50,000, 50,000 and 45,000 € respectively. |
The Award consists of a total sum of 150,000 €, of which the Award winner will receive the sum of 50,000 € as a research prize.
The remaining 100,000 € will be used to support the Award winner's research activity.
The amounts intended for supporting the Award winner's research activity will be paid in two annual instalments, starting in the year when the award was presented, of 50,000 and 50,000 € respectively.
|
| Once the Award has been granted and accepted, the Award winner will inform the Fundación Lilly of the research activity to be undertaken, which should comply both in terms of the subject and the quality with the award winner's scientific trajectory. |
| TERMS |
1.The Candidates should be scientists who have made a significant contribution to the development of Biomedical Research (both at a preclinical and clinical level) in Spain, and should have a current research activity in a Spanish institution or centre which enables them to continue to contribute to this development over the coming years.
2. Candidates for the Awards should be proposed by persons or institutions in the Biomedical scientific field or in Health Sciences.
3. Proposals should be formalised by means of a letter sent to:
The Director
Fundación Lilly
c/ Velazquez 94 - 28006 Madrid
and should include the candidate's curriculum vitae and a brief description of the reasons for their proposal, by completing the form on this web page, and the names, addresses, telephone numbers and/or e-mail addresses of three researchers whom the FUNDACIÓN LILLY can contact for a reference, at least one of whom should be working in research outside Spain.
4. Research assistance included in these awards lasts for two or three years.
5. The deadline for presentation of proposals will end on 7th March 2003. |
| SELECTION |
|
Candidatures will be assessed by
members of the Scientific Advisory Board of the Fundación Lilly, acting as a Jury,
who include:
Mr. Mariano Barbacid Montalbán, Director of the Carlos III National Centre for Oncological Research.
Mr. Juan Carlos Gómez Pérez, Medical Director of Lilly S.A.
Mr. Federico Mayor Menéndez, Chair of Biochemistry and Biology at the Universidad Autónoma de Madrid, Severo Ochoa Molecular Biology Centre.
Mr. Francisco Zaragozá, Chair of Pharmacology at the University of Alcalá de Henares.
Mr. Julio Alvarez Builla, Chair of Organic Chemistry at the University of Alcalá de Henares.
Mr. Juan José López-Ibor Aliño, Chair and Head of the Department of Psychiatry at the Hospital Clínico San Carlos in Madrid.
Mr. Manuel Serrano Rios, Chair and Head of the Department of Internal Medicine at the Hospital Clínico San Carlos in Madrid.
Mr. Antonio Artigas, Director of the Critical Care Centre and Department of Intensive Medicine at the Parc Taulí Hospital Consortium in Sabadell, Barcelona.
Mr. Joaquín Calaf Alsina, Director of the Department of Gynaecology and Obstetrics at the Hospital de la Santa Cruz y San Pablo in Barcelona.
Mr. Hernán Cortés Funes, Head of the Department of Oncology at the Hospital 12 de Octubre in Madrid.
Mr. José María Martín Moreno, Epidemiologist and Specialist in Public Health and Healthcare Management.
The secretary to the Jury is Mr. José Antonio Gutiérrez Fuentes, Director of the Fundación Lilly.
At its discretion, the jury may declare that either section of the award will not be granted.
The awards and funding will be presented to the selected Researchers during an annual award ceremony organised by the Fundación Lilly for this purpose.
This announcement is governed by its rules, which interested parties may request from the Fundación Lilly (c/ Velázquez 94, 28006 Madrid, Tel. 91 781 50 70/71; Fax 91 781 50 79 or at: www.fundacionlilly.com).
|
|
|
|
